Viagra and Pharma: A Volatile Bet?

The history of Viagra presents a intricate picture for investors. While the initial launch generated significant returns, the lapse of its exclusive rights opened the avenue to cheaper competitors, dramatically eroding revenue. This creates a unique challenge for pharmaceutical companies depending on similar blockbuster medications, suggesting that

read more

Elite Gambler's The Pill: A Precarious Bet

The emergence of so-called "Premium Gambler's Sildenafil" – often referring to exceptionally high doses ordered by disreputable physicians – represents a particularly alarming trend. While typical dosages of Viagra are intended for treating erectile dysfunction safely in most men, these significantly elevated quantities pose a serious threat to

read more